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What  is the  adequate  mononuclear  cell  content  for
selecting umbilical  cord  blood  units for
anteeing a CD34+ count ≥2 × 106 (Table 1).
Previously, we applied a ROC model to analyze the correla-
tion between volume, TNC and MNC with the CD34+ count,
and established the TNC content as the most signiﬁcant
parameter.3 In the present report, we  evaluated the degree to
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Figure 1 – Receiver operating characteristic (ROC) curve
analysis comparing the total nucleated cell (TNC) count
[area under the curve (AUC) = 0.822] vs. the absolute
mononuclear cell (MNC) count (AUC = 0.806) as criteria forcryopreservation?
Over the past decade umbilical cord blood (UCB) has been
used as an alternative source of hematopoietic stem cells
(HSCs). Worldwide, more  than 500 000 cord blood units (CBUs)
have been cryopreserved and stored in banks.1 It has been
shown that the CD34+ cell content inﬂuences engraftment
and survival after UBC transplants.2 Although there are no
fully agreed upon standardized criteria for selecting units for
cryopreservation, most cord blood banks use a combination of
the total nucleated cell (TNC) count and volume; a TNC count
≥8 × 108 has been considered the best predictor for CD34+
HSC content.3 No such parameter has been established for the
mononuclear cell count (MNC).
Recently it has been proposed that in order to assure that
stem cells will perform as intended, the quality and potency
of UCB hematopoietic progenitor cells should be measured.
This can only be done using the MNC  fraction, not the TNC
fraction.4,5 Given this recent development, we  assessed the
possibility of using the MNC  to predict the CD34+ cell content
in cord blood and its relationship to the TNC count.
We analyzed 857 CBUs received at the cord blood bank
of the Hematology Department of the Hospital Universitario
‘Dr. Jose E. Gonzalez’, Universidad Autónoma de Nuevo León
in Monterrey, México. TNC counts were determined with an
automated hematology analyzer (Sysmex XT 2000, Sysmex,
Mundelein, IL, USA) using a multiangle polarized scatter sepa-
ration technique which provides the primary TNC count. Total
TNC counts were calculated by multiplying the primary TNC
count (per microliter) by the total volume of the CBU. Total
MNC  counts were calculated by adding the absolute lympho-
cyte and monocyte counts (per microliter) reported in the
complete blood count and then multiplying this value by the
total volume of the bag. CD34+ cell counts were determined
by employing ﬂuorescein isothiocyanate labeled anti-CD45+
monoclonal antibodies (FITC; Becton Dickinson, San Jose,
CA, USA) and monoclonal anti-human CD34+ Class III/FITC,
Clone BIRMA K-3 (DAKO, Denmark) in a FACSCalibur ﬂow
cytometer (Becton Dickinson). The mean collected volume
of the CBUs was 96.98 ± 28.88 mL  and the mean TNC, MNC
and CD34+ counts were 9.95 ± 4.97 × 108, 5.10 ± 2.65 × 108 and
2.95 ± 2.33 × 106, respectively. We divided the CBUs into twogroups depending on the CD34+ cell count (less than or greater
than 2 × 106). Receiver operating characteristic (ROC) curve
analysis comparing TNC and MNC to select CBUs with a CD34+
cell count of ≥2 × 106 were designed. The optimal operating
points for TNC and MNC that best correlated with a CD34+
count ≥2 × 106 were determined (Table 1; Figure 1). A sig-
niﬁcant difference between TNC and MNC was not found
(p-value = 0.059). In addition, a TNC >7.94 × 108 was selected
by ROC analysis as the point that best reﬂects the MNC  guar-selecting cord blood units suitable for cryopreservation,
that is, a CD34+ cell content ≥2.0 × 106. No signiﬁcant
difference was found (p-value = 0.059).
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Table 1 – A comparison between total nucleated cells and mononuclear cells for the selection of cord blood units with
CD34+ counts ≥2 × 106.
Performance evaluation Comparison of ROC curves
Sensitivity Speciﬁcity −PV +PV +LR −LR AUC Difference
between areas
p-Value
TNC cutoff (×108) 0.822
>8.33 77.86 69.88 67.70 79.60 2.59 0.32
>7.94* 80.97 64.33 69.20 77.40 2.27 0.30
MNC cutoff (×108) 0.806
>4.05 80.78 66.37 69.60 78.30 2.40 0.29 0.0159 0.059
TNC: total nucleated cell; MNC: mononuclear cell; ROC: receiver operating characteristic; −PV: negative predictive value; +PV: positive predictive
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5value; +LR: positive likelihood ratio; −LR: negative likelihood ratio; AU
∗ Optimal operating point chosen by ROC analysis for TNC.
hich a TNC count ≥8 × 108 reﬂects a MNC  content to meet
he required CD34+ count and found that the mean MNC count
as 5.10 × 108 (63.75% of the mean TNC count). Moreover, ROC
nalysis selected a MNC  of 4.05 × 108 as the cutoff point to
chieve an optimal CD34+ count (≥2 × 106).
Thus, our ﬁndings conﬁrm that the current TNC standard
or UCB cryopreservation gives reliable information on the
NC  content and suggests a cutoff point for the lowest frac-
ion for transplantation purposes.
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